Back to News
Research
Closing the data loop in AI-driven drug discovery
MIT Tech Review·July 27, 2026·1 min read

From the source
Drug discovery is a high-cost, high-risk endeavor that is under growing pressure from a market increasingly defined by first-mover advantage. Since the 1950s, the cost of developing new pharmaceuticals has roughly doubled every nine years—a phenomenon known as Eroom’s Law. Today, bringing a new drug to market takes an average of 10-15 years and costs…
The full text couldn't be loaded here (the source may require a subscription).
View original at MIT Tech ReviewKeep reading
OpenAI called the Hugging Face attack unprecedented. But we’ve been here before. MIT Tech Review · 8h agoHow lasers could help provide fuel for nuclear reactorsMIT Tech Review · 12h agoThe Download: lasers for nuclear fuel, and organ preservation advancesMIT Tech Review · 14h agoThe path to artificial superintelligenceMIT Tech Review · 14h ago
Was this useful?